Guardant Health, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced total revenue was USD 92.101 million compared to USD 66.335 million a year ago. Operating loss was USD 97.642 million compared to USD 54.620 million a year ago. Net loss was USD 97.575 million compared to USD 54.639 million a year ago. Basic loss per share from continuing operations was USD 0.96 compared to USD 0.57 a year ago. For the half year, total revenue was USD 170.766 million compared to USD 133.845 million a year ago. Operating loss was USD 205.505 million compared to USD 89.532 million a year ago. Net loss was USD 207.233 million compared to USD 82.368 million a year ago. Basic loss per share from continuing operations was USD 2.05 compared to USD 0.87 a year ago.